List of Tables
Table 1. Global Janus Kinases Inhibitor Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Janus Kinases Inhibitor Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Janus Kinases Inhibitor Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Janus Kinases Inhibitor Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Janus Kinases Inhibitor Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Janus Kinases Inhibitor Drugs Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Janus Kinases Inhibitor Drugs Sales by Region (2020-2025) & (K Units)
Table 8. Global Janus Kinases Inhibitor Drugs Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Janus Kinases Inhibitor Drugs Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Janus Kinases Inhibitor Drugs Sales Share by Manufacturers (2020-2025)
Table 12. Global Janus Kinases Inhibitor Drugs Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Janus Kinases Inhibitor Drugs Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Janus Kinases Inhibitor Drugs by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Janus Kinases Inhibitor Drugs as of 2024)
Table 16. Global Janus Kinases Inhibitor Drugs Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Janus Kinases Inhibitor Drugs Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Janus Kinases Inhibitor Drugs Manufacturing Base and Headquarters
Table 19. Global Janus Kinases Inhibitor Drugs Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Janus Kinases Inhibitor Drugs Sales by Type (2020-2025) & (K Units)
Table 23. Global Janus Kinases Inhibitor Drugs Sales by Type (2026-2031) & (K Units)
Table 24. Global Janus Kinases Inhibitor Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Janus Kinases Inhibitor Drugs Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Janus Kinases Inhibitor Drugs ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Janus Kinases Inhibitor Drugs Sales by Application (2020-2025) & (K Units)
Table 29. Global Janus Kinases Inhibitor Drugs Sales by Application (2026-2031) & (K Units)
Table 30. Janus Kinases Inhibitor Drugs High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Janus Kinases Inhibitor Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Janus Kinases Inhibitor Drugs Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Janus Kinases Inhibitor Drugs ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Janus Kinases Inhibitor Drugs Growth Accelerators and Market Barriers
Table 37. North America Janus Kinases Inhibitor Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Janus Kinases Inhibitor Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Janus Kinases Inhibitor Drugs Growth Accelerators and Market Barriers
Table 40. Europe Janus Kinases Inhibitor Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Janus Kinases Inhibitor Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Janus Kinases Inhibitor Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Janus Kinases Inhibitor Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Janus Kinases Inhibitor Drugs Growth Accelerators and Market Barriers
Table 45. Southeast Asia Janus Kinases Inhibitor Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Janus Kinases Inhibitor Drugs Investment Opportunities and Key Challenges
Table 47. Central and South America Janus Kinases Inhibitor Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Janus Kinases Inhibitor Drugs Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Janus Kinases Inhibitor Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. AbbVie Corporation Information
Table 51. AbbVie Description and Major Businesses
Table 52. AbbVie Product Models, Descriptions and Specifications
Table 53. AbbVie Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. AbbVie Sales Value Proportion by Product in 2024
Table 55. AbbVie Sales Value Proportion by Application in 2024
Table 56. AbbVie Sales Value Proportion by Geographic Area in 2024
Table 57. AbbVie Janus Kinases Inhibitor Drugs SWOT Analysis
Table 58. AbbVie Recent Developments
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Major Businesses
Table 61. Pfizer Product Models, Descriptions and Specifications
Table 62. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Pfizer Sales Value Proportion by Product in 2024
Table 64. Pfizer Sales Value Proportion by Application in 2024
Table 65. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 66. Pfizer Janus Kinases Inhibitor Drugs SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Galapagos Corporation Information
Table 69. Galapagos Description and Major Businesses
Table 70. Galapagos Product Models, Descriptions and Specifications
Table 71. Galapagos Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Galapagos Sales Value Proportion by Product in 2024
Table 73. Galapagos Sales Value Proportion by Application in 2024
Table 74. Galapagos Sales Value Proportion by Geographic Area in 2024
Table 75. Galapagos Janus Kinases Inhibitor Drugs SWOT Analysis
Table 76. Galapagos Recent Developments
Table 77. Gilead Sciences Corporation Information
Table 78. Gilead Sciences Description and Major Businesses
Table 79. Gilead Sciences Product Models, Descriptions and Specifications
Table 80. Gilead Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Gilead Sciences Sales Value Proportion by Product in 2024
Table 82. Gilead Sciences Sales Value Proportion by Application in 2024
Table 83. Gilead Sciences Sales Value Proportion by Geographic Area in 2024
Table 84. Gilead Sciences Janus Kinases Inhibitor Drugs SWOT Analysis
Table 85. Gilead Sciences Recent Developments
Table 86. Theravance Biopharma Corporation Information
Table 87. Theravance Biopharma Description and Major Businesses
Table 88. Theravance Biopharma Product Models, Descriptions and Specifications
Table 89. Theravance Biopharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Theravance Biopharma Sales Value Proportion by Product in 2024
Table 91. Theravance Biopharma Sales Value Proportion by Application in 2024
Table 92. Theravance Biopharma Sales Value Proportion by Geographic Area in 2024
Table 93. Theravance Biopharma Janus Kinases Inhibitor Drugs SWOT Analysis
Table 94. Theravance Biopharma Recent Developments
Table 95. Incyte Corporation Information
Table 96. Incyte Description and Major Businesses
Table 97. Incyte Product Models, Descriptions and Specifications
Table 98. Incyte Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Incyte Recent Developments
Table 100. Eli Lilly and Company Corporation Information
Table 101. Eli Lilly and Company Description and Major Businesses
Table 102. Eli Lilly and Company Product Models, Descriptions and Specifications
Table 103. Eli Lilly and Company Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Eli Lilly and Company Recent Developments
Table 105. CTI BioPharma Corporation Information
Table 106. CTI BioPharma Description and Major Businesses
Table 107. CTI BioPharma Product Models, Descriptions and Specifications
Table 108. CTI BioPharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. CTI BioPharma Recent Developments
Table 110. GSK Corporation Information
Table 111. GSK Description and Major Businesses
Table 112. GSK Product Models, Descriptions and Specifications
Table 113. GSK Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. GSK Recent Developments
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Major Businesses
Table 117. Novartis Product Models, Descriptions and Specifications
Table 118. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Novartis Recent Developments
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Major Businesses
Table 122. Sanofi Product Models, Descriptions and Specifications
Table 123. Sanofi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Sanofi Recent Developments
Table 125. Bristol-Myers Squibb Corporation Information
Table 126. Bristol-Myers Squibb Description and Major Businesses
Table 127. Bristol-Myers Squibb Product Models, Descriptions and Specifications
Table 128. Bristol-Myers Squibb Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Bristol-Myers Squibb Recent Developments
Table 130. Vertex Pharmaceuticals Corporation Information
Table 131. Vertex Pharmaceuticals Description and Major Businesses
Table 132. Vertex Pharmaceuticals Product Models, Descriptions and Specifications
Table 133. Vertex Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Vertex Pharmaceuticals Recent Developments
Table 135. Astellas Pharma Corporation Information
Table 136. Astellas Pharma Description and Major Businesses
Table 137. Astellas Pharma Product Models, Descriptions and Specifications
Table 138. Astellas Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Astellas Pharma Recent Developments
Table 140. Amneal Pharmaceuticals Corporation Information
Table 141. Amneal Pharmaceuticals Description and Major Businesses
Table 142. Amneal Pharmaceuticals Product Models, Descriptions and Specifications
Table 143. Amneal Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Amneal Pharmaceuticals Recent Developments
Table 145. AstraZeneca Corporation Information
Table 146. AstraZeneca Description and Major Businesses
Table 147. AstraZeneca Product Models, Descriptions and Specifications
Table 148. AstraZeneca Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. AstraZeneca Recent Developments
Table 150. Aclaris Therapeutics Corporation Information
Table 151. Aclaris Therapeutics Description and Major Businesses
Table 152. Aclaris Therapeutics Product Models, Descriptions and Specifications
Table 153. Aclaris Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Aclaris Therapeutics Recent Developments
Table 155. BioCryst Pharmaceuticals Corporation Information
Table 156. BioCryst Pharmaceuticals Description and Major Businesses
Table 157. BioCryst Pharmaceuticals Product Models, Descriptions and Specifications
Table 158. BioCryst Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. BioCryst Pharmaceuticals Recent Developments
Table 160. Biogen Corporation Information
Table 161. Biogen Description and Major Businesses
Table 162. Biogen Product Models, Descriptions and Specifications
Table 163. Biogen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Biogen Recent Developments
Table 165. Reistone Biopharma Corporation Information
Table 166. Reistone Biopharma Description and Major Businesses
Table 167. Reistone Biopharma Product Models, Descriptions and Specifications
Table 168. Reistone Biopharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. Reistone Biopharma Recent Developments
Table 170. Key Raw Materials Distribution
Table 171. Raw Materials Key Suppliers
Table 172. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 173. Milestones in Production Technology Evolution
Table 174. Distributors List
Table 175. Market Trends and Market Evolution
Table 176. Market Drivers and Opportunities
Table 177. Market Challenges, Risks, and Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Janus Kinases Inhibitor Drugs Product Picture
Figure 2. Global Janus Kinases Inhibitor Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Injectable Product Picture
Figure 4. Oral Product Picture
Figure 5. Global Janus Kinases Inhibitor Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Oncology
Figure 7. Musculoskeletal
Figure 8. Gastroenterology
Figure 9. Other
Figure 10. Janus Kinases Inhibitor Drugs Report Years Considered
Figure 11. Global Janus Kinases Inhibitor Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 13. Global Janus Kinases Inhibitor Drugs Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Janus Kinases Inhibitor Drugs Revenue Market Share by Region (2020-2031)
Figure 15. Global Janus Kinases Inhibitor Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Janus Kinases Inhibitor Drugs Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Janus Kinases Inhibitor Drugs Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Janus Kinases Inhibitor Drugs Sales Volume Market Share in 2024
Figure 19. Global Janus Kinases Inhibitor Drugs Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Injectable Revenue Market Share by Manufacturer in 2024
Figure 22. Oral Revenue Market Share by Manufacturer in 2024
Figure 23. Global Janus Kinases Inhibitor Drugs Sales Market Share by Type (2020-2031)
Figure 24. Global Janus Kinases Inhibitor Drugs Revenue Market Share by Type (2020-2031)
Figure 25. Global Janus Kinases Inhibitor Drugs Sales Market Share by Application (2020-2031)
Figure 26. Global Janus Kinases Inhibitor Drugs Revenue Market Share by Application (2020-2031)
Figure 27. North America Janus Kinases Inhibitor Drugs Sales YoY (2020-2031) & (K Units)
Figure 28. North America Janus Kinases Inhibitor Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) in 2024
Figure 30. North America Janus Kinases Inhibitor Drugs Sales Volume (K Units) by Type (2020- 2031)
Figure 31. North America Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Janus Kinases Inhibitor Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 33. North America Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Janus Kinases Inhibitor Drugs Sales YoY (2020-2031) & (K Units)
Figure 38. Europe Janus Kinases Inhibitor Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) in 2024
Figure 40. Europe Janus Kinases Inhibitor Drugs Sales Volume (K Units) by Type (2020-2031)
Figure 41. Europe Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Janus Kinases Inhibitor Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 43. Europe Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 45. France Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Janus Kinases Inhibitor Drugs Sales YoY (2020-2031) & (K Units)
Figure 50. Asia-Pacific Janus Kinases Inhibitor Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Janus Kinases Inhibitor Drugs Sales Volume (K Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Janus Kinases Inhibitor Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 55. Asia-Pacific Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 60. India Janus Kinases Inhibitor Drugs Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Janus Kinases Inhibitor Drugs Sales YoY (2020-2031) & (K Units)
Figure 62. Central and South America Janus Kinases Inhibitor Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Janus Kinases Inhibitor Drugs Sales Volume (K Units) by Type (2021-2031)
Figure 65. Central and South America Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Janus Kinases Inhibitor Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 67. Central and South America Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Janus Kinases Inhibitor Drugs Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Janus Kinases Inhibitor Drugs Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Janus Kinases Inhibitor Drugs Sales YoY (2020-2031) & (K Units)
Figure 71. Middle East and Africa Janus Kinases Inhibitor Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Janus Kinases Inhibitor Drugs Sales Volume (K Units) by Type (2021-2031)
Figure 74. South America Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Janus Kinases Inhibitor Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 76. Middle East and Africa Janus Kinases Inhibitor Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Janus Kinases Inhibitor Drugs Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Janus Kinases Inhibitor Drugs Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Janus Kinases Inhibitor Drugs Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Janus Kinases Inhibitor Drugs Revenue (2020-2025) & (US$ Million)
Figure 81. Janus Kinases Inhibitor Drugs Industry Chain Mapping
Figure 82. Regional Janus Kinases Inhibitor Drugs Manufacturing Base Distribution (%)
Figure 83. Global Janus Kinases Inhibitor Drugs Production Market Share by Region (2020-2031)
Figure 84. Janus Kinases Inhibitor Drugs Production Process
Figure 85. Regional Janus Kinases Inhibitor Drugs Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
